An interesting article by Ito et al. showed the successful combined immunotherapy using interleukin-2 (IL-2) and granulocyte macrophage-colony stimulating factor (GM-CSF) with magnetic hyperthermia in mouse melanoma tumor [15]. This evidence concerns the gene IL2 and melanoma.